Proof of concept for stereotactic body radiation therapy in the treatment of functional neuroendocrine neoplasms
Sten Myrehaug, Julie Hallet, William Chu, Elaine Yong, Calvin Law, Angela Assal, Olexandra Koshkina, Alexander V. Louie and Simron Singh
Dysregulated hormonal production remains a challenge in the management of neuroendocrine neoplasms (NEN). We report 4 cases of patients with functional NEN treated with stereotactic body radiation therapy (SBRT) to either the primary/dominant metastatic site of disease or the end organ of hormonal release. No significant toxicities were observed during or after treatment. Each patient has had biochemical, clinical and radiographic response to therapy, providing proof of concept that SBRT is an effective therapeutic strategy for functional neuroendocrine neoplasms.
Keywords: Stereotactic radiation, neuroendocrine, functional, insulinoma, glucagonoma
After payment has been processed for your order of a digital copy (PDF) of this article, you will see a download link on your completed order page and also receive an email containing a download link. The links, which will enable you to download one copy of the article, will expire after 24 hours.